Targeted therapy is?a type of cancer treatment that uses drugs or other substances to precisely identify and attack certain types of cancer cells. A targeted therapy can be used by itself or in combination with other treatments, such as traditional or standard chemotherapy, surgery, or radiation therapy.
This report contains market size and forecasts of Targeted Small Molecule Drug in Global, including the following market information:
Global Targeted Small Molecule Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Targeted Small Molecule Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Sorafenib Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Targeted Small Molecule Drug include Bayer, Eisai, Zelgen, Cipla, Natco Pharma, AstraZeneca, Novartis, Roche and Bristol-Myers Squibb, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
Publisher has surveyed the Targeted Small Molecule Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Targeted Small Molecule Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Targeted Small Molecule Drug Market Segment Percentages, by Type, 2021 (%)
Sorafenib
Lenvatinib
Regorafenib
Osimertinib
Anlotinib
Alectinib
Other
Global Targeted Small Molecule Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Targeted Small Molecule Drug Market Segment Percentages, by Application, 2021 (%)
Hospital
Retail Pharmacy
Other
Global Targeted Small Molecule Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Targeted Small Molecule Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Targeted Small Molecule Drug revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Targeted Small Molecule Drug revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Bayer
Eisai
Zelgen
Cipla
Natco Pharma
AstraZeneca
Novartis
Roche
Bristol-Myers Squibb
Pfizer
BEACON Pharma
Jiangxi Shanxiang
Yao Pharma
CSPC
CHIATAI Tianqing
Simcere
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Targeted Small Molecule Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Targeted Small Molecule Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Targeted Small Molecule Drug Overall Market Size
2.1 Global Targeted Small Molecule Drug Market Size: 2021 VS 2028
2.2 Global Targeted Small Molecule Drug Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Targeted Small Molecule Drug Players in Global Market
3.2 Top Global Targeted Small Molecule Drug Companies Ranked by Revenue
3.3 Global Targeted Small Molecule Drug Revenue by Companies
3.4 Top 3 and Top 5 Targeted Small Molecule Drug Companies in Global Market, by Revenue in 2021
3.5 Global Companies Targeted Small Molecule Drug Product Type
3.6 Tier 1, Tier 2 and Tier 3 Targeted Small Molecule Drug Players in Global Market
3.6.1 List of Global Tier 1 Targeted Small Molecule Drug Companies
3.6.2 List of Global Tier 2 and Tier 3 Targeted Small Molecule Drug Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type - Global Targeted Small Molecule Drug Market Size Markets, 2021 & 2028
4.1.2 Sorafenib
4.1.3 Lenvatinib
4.1.4 Regorafenib
4.1.5 Osimertinib
4.1.6 Anlotinib
4.1.7 Alectinib
4.1.8 Other
4.2 By Type - Global Targeted Small Molecule Drug Revenue & Forecasts
4.2.1 By Type - Global Targeted Small Molecule Drug Revenue, 2017-2022
4.2.2 By Type - Global Targeted Small Molecule Drug Revenue, 2023-2028
4.2.3 By Type - Global Targeted Small Molecule Drug Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Targeted Small Molecule Drug Market Size, 2021 & 2028
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application - Global Targeted Small Molecule Drug Revenue & Forecasts
5.2.1 By Application - Global Targeted Small Molecule Drug Revenue, 2017-2022
5.2.2 By Application - Global Targeted Small Molecule Drug Revenue, 2023-2028
5.2.3 By Application - Global Targeted Small Molecule Drug Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region - Global Targeted Small Molecule Drug Market Size, 2021 & 2028
6.2 By Region - Global Targeted Small Molecule Drug Revenue & Forecasts
6.2.1 By Region - Global Targeted Small Molecule Drug Revenue, 2017-2022
6.2.2 By Region - Global Targeted Small Molecule Drug Revenue, 2023-2028
6.2.3 By Region - Global Targeted Small Molecule Drug Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Targeted Small Molecule Drug Revenue, 2017-2028
6.3.2 US Targeted Small Molecule Drug Market Size, 2017-2028
6.3.3 Canada Targeted Small Molecule Drug Market Size, 2017-2028
6.3.4 Mexico Targeted Small Molecule Drug Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Targeted Small Molecule Drug Revenue, 2017-2028
6.4.2 Germany Targeted Small Molecule Drug Market Size, 2017-2028
6.4.3 France Targeted Small Molecule Drug Market Size, 2017-2028
6.4.4 U.K. Targeted Small Molecule Drug Market Size, 2017-2028
6.4.5 Italy Targeted Small Molecule Drug Market Size, 2017-2028
6.4.6 Russia Targeted Small Molecule Drug Market Size, 2017-2028
6.4.7 Nordic Countries Targeted Small Molecule Drug Market Size, 2017-2028
6.4.8 Benelux Targeted Small Molecule Drug Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Targeted Small Molecule Drug Revenue, 2017-2028
6.5.2 China Targeted Small Molecule Drug Market Size, 2017-2028
6.5.3 Japan Targeted Small Molecule Drug Market Size, 2017-2028
6.5.4 South Korea Targeted Small Molecule Drug Market Size, 2017-2028
6.5.5 Southeast Asia Targeted Small Molecule Drug Market Size, 2017-2028
6.5.6 India Targeted Small Molecule Drug Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Targeted Small Molecule Drug Revenue, 2017-2028
6.6.2 Brazil Targeted Small Molecule Drug Market Size, 2017-2028
6.6.3 Argentina Targeted Small Molecule Drug Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Targeted Small Molecule Drug Revenue, 2017-2028
6.7.2 Turkey Targeted Small Molecule Drug Market Size, 2017-2028
6.7.3 Israel Targeted Small Molecule Drug Market Size, 2017-2028
6.7.4 Saudi Arabia Targeted Small Molecule Drug Market Size, 2017-2028
6.7.5 UAE Targeted Small Molecule Drug Market Size, 2017-2028
7 Players Profiles
7.1 Bayer
7.1.1 Bayer Corporate Summary
7.1.2 Bayer Business Overview
7.1.3 Bayer Targeted Small Molecule Drug Major Product Offerings
7.1.4 Bayer Targeted Small Molecule Drug Revenue in Global Market (2017-2022)
7.1.5 Bayer Key News
7.2 Eisai
7.2.1 Eisai Corporate Summary
7.2.2 Eisai Business Overview
7.2.3 Eisai Targeted Small Molecule Drug Major Product Offerings
7.2.4 Eisai Targeted Small Molecule Drug Revenue in Global Market (2017-2022)
7.2.5 Eisai Key News
7.3 Zelgen
7.3.1 Zelgen Corporate Summary
7.3.2 Zelgen Business Overview
7.3.3 Zelgen Targeted Small Molecule Drug Major Product Offerings
7.3.4 Zelgen Targeted Small Molecule Drug Revenue in Global Market (2017-2022)
7.3.5 Zelgen Key News
7.4 Cipla
7.4.1 Cipla Corporate Summary
7.4.2 Cipla Business Overview
7.4.3 Cipla Targeted Small Molecule Drug Major Product Offerings
7.4.4 Cipla Targeted Small Molecule Drug Revenue in Global Market (2017-2022)
7.4.5 Cipla Key News
7.5 Natco Pharma
7.5.1 Natco Pharma Corporate Summary
7.5.2 Natco Pharma Business Overview
7.5.3 Natco Pharma Targeted Small Molecule Drug Major Product Offerings
7.5.4 Natco Pharma Targeted Small Molecule Drug Revenue in Global Market (2017-2022)
7.5.5 Natco Pharma Key News
7.6 AstraZeneca
7.6.1 AstraZeneca Corporate Summary
7.6.2 AstraZeneca Business Overview
7.6.3 AstraZeneca Targeted Small Molecule Drug Major Product Offerings
7.6.4 AstraZeneca Targeted Small Molecule Drug Revenue in Global Market (2017-2022)
7.6.5 AstraZeneca Key News
7.7 Novartis
7.7.1 Novartis Corporate Summary
7.7.2 Novartis Business Overview
7.7.3 Novartis Targeted Small Molecule Drug Major Product Offerings
7.7.4 Novartis Targeted Small Molecule Drug Revenue in Global Market (2017-2022)
7.7.5 Novartis Key News
7.8 Roche
7.8.1 Roche Corporate Summary
7.8.2 Roche Business Overview
7.8.3 Roche Targeted Small Molecule Drug Major Product Offerings
7.8.4 Roche Targeted Small Molecule Drug Revenue in Global Market (2017-2022)
7.8.5 Roche Key News
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Corporate Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb Targeted Small Molecule Drug Major Product Offerings
7.9.4 Bristol-Myers Squibb Targeted Small Molecule Drug Revenue in Global Market (2017-2022)
7.9.5 Bristol-Myers Squibb Key News
7.10 Pfizer
7.10.1 Pfizer Corporate Summary
7.10.2 Pfizer Business Overview
7.10.3 Pfizer Targeted Small Molecule Drug Major Product Offerings
7.10.4 Pfizer Targeted Small Molecule Drug Revenue in Global Market (2017-2022)
7.10.5 Pfizer Key News
7.11 BEACON Pharma
7.11.1 BEACON Pharma Corporate Summary
7.11.2 BEACON Pharma Business Overview
7.11.3 BEACON Pharma Targeted Small Molecule Drug Major Product Offerings
7.11.4 BEACON Pharma Targeted Small Molecule Drug Revenue in Global Market (2017-2022)
7.11.5 BEACON Pharma Key News
7.12 Jiangxi Shanxiang
7.12.1 Jiangxi Shanxiang Corporate Summary
7.12.2 Jiangxi Shanxiang Business Overview
7.12.3 Jiangxi Shanxiang Targeted Small Molecule Drug Major Product Offerings
7.12.4 Jiangxi Shanxiang Targeted Small Molecule Drug Revenue in Global Market (2017-2022)
7.12.5 Jiangxi Shanxiang Key News
7.13 Yao Pharma
7.13.1 Yao Pharma Corporate Summary
7.13.2 Yao Pharma Business Overview
7.13.3 Yao Pharma Targeted Small Molecule Drug Major Product Offerings
7.13.4 Yao Pharma Targeted Small Molecule Drug Revenue in Global Market (2017-2022)
7.13.5 Yao Pharma Key News
7.14 CSPC
7.14.1 CSPC Corporate Summary
7.14.2 CSPC Business Overview
7.14.3 CSPC Targeted Small Molecule Drug Major Product Offerings
7.14.4 CSPC Targeted Small Molecule Drug Revenue in Global Market (2017-2022)
7.14.5 CSPC Key News
7.15 CHIATAI Tianqing
7.15.1 CHIATAI Tianqing Corporate Summary
7.15.2 CHIATAI Tianqing Business Overview
7.15.3 CHIATAI Tianqing Targeted Small Molecule Drug Major Product Offerings
7.15.4 CHIATAI Tianqing Targeted Small Molecule Drug Revenue in Global Market (2017-2022)
7.15.5 CHIATAI Tianqing Key News
7.16 Simcere
7.16.1 Simcere Corporate Summary
7.16.2 Simcere Business Overview
7.16.3 Simcere Targeted Small Molecule Drug Major Product Offerings
7.16.4 Simcere Targeted Small Molecule Drug Revenue in Global Market (2017-2022)
7.16.5 Simcere Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Targeted Small Molecule Drug Market Opportunities & Trends in Global Market
Table 2. Targeted Small Molecule Drug Market Drivers in Global Market
Table 3. Targeted Small Molecule Drug Market Restraints in Global Market
Table 4. Key Players of Targeted Small Molecule Drug in Global Market
Table 5. Top Targeted Small Molecule Drug Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Targeted Small Molecule Drug Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Targeted Small Molecule Drug Revenue Share by Companies, 2017-2022
Table 8. Global Companies Targeted Small Molecule Drug Product Type
Table 9. List of Global Tier 1 Targeted Small Molecule Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Targeted Small Molecule Drug Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type - Global Targeted Small Molecule Drug Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Targeted Small Molecule Drug Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Targeted Small Molecule Drug Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application - Global Targeted Small Molecule Drug Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Targeted Small Molecule Drug Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Targeted Small Molecule Drug Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region - Global Targeted Small Molecule Drug Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Targeted Small Molecule Drug Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Targeted Small Molecule Drug Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Targeted Small Molecule Drug Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Targeted Small Molecule Drug Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Targeted Small Molecule Drug Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Targeted Small Molecule Drug Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Targeted Small Molecule Drug Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Targeted Small Molecule Drug Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Targeted Small Molecule Drug Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Targeted Small Molecule Drug Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Targeted Small Molecule Drug Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Targeted Small Molecule Drug Revenue, (US$, Mn), 2023-2028
Table 30. Bayer Corporate Summary
Table 31. Bayer Targeted Small Molecule Drug Product Offerings
Table 32. Bayer Targeted Small Molecule Drug Revenue (US$, Mn), (2017-2022)
Table 33. Eisai Corporate Summary
Table 34. Eisai Targeted Small Molecule Drug Product Offerings
Table 35. Eisai Targeted Small Molecule Drug Revenue (US$, Mn), (2017-2022)
Table 36. Zelgen Corporate Summary
Table 37. Zelgen Targeted Small Molecule Drug Product Offerings
Table 38. Zelgen Targeted Small Molecule Drug Revenue (US$, Mn), (2017-2022)
Table 39. Cipla Corporate Summary
Table 40. Cipla Targeted Small Molecule Drug Product Offerings
Table 41. Cipla Targeted Small Molecule Drug Revenue (US$, Mn), (2017-2022)
Table 42. Natco Pharma Corporate Summary
Table 43. Natco Pharma Targeted Small Molecule Drug Product Offerings
Table 44. Natco Pharma Targeted Small Molecule Drug Revenue (US$, Mn), (2017-2022)
Table 45. AstraZeneca Corporate Summary
Table 46. AstraZeneca Targeted Small Molecule Drug Product Offerings
Table 47. AstraZeneca Targeted Small Molecule Drug Revenue (US$, Mn), (2017-2022)
Table 48. Novartis Corporate Summary
Table 49. Novartis Targeted Small Molecule Drug Product Offerings
Table 50. Novartis Targeted Small Molecule Drug Revenue (US$, Mn), (2017-2022)
Table 51. Roche Corporate Summary
Table 52. Roche Targeted Small Molecule Drug Product Offerings
Table 53. Roche Targeted Small Molecule Drug Revenue (US$, Mn), (2017-2022)
Table 54. Bristol-Myers Squibb Corporate Summary
Table 55. Bristol-Myers Squibb Targeted Small Molecule Drug Product Offerings
Table 56. Bristol-Myers Squibb Targeted Small Molecule Drug Revenue (US$, Mn), (2017-2022)
Table 57. Pfizer Corporate Summary
Table 58. Pfizer Targeted Small Molecule Drug Product Offerings
Table 59. Pfizer Targeted Small Molecule Drug Revenue (US$, Mn), (2017-2022)
Table 60. BEACON Pharma Corporate Summary
Table 61. BEACON Pharma Targeted Small Molecule Drug Product Offerings
Table 62. BEACON Pharma Targeted Small Molecule Drug Revenue (US$, Mn), (2017-2022)
Table 63. Jiangxi Shanxiang Corporate Summary
Table 64. Jiangxi Shanxiang Targeted Small Molecule Drug Product Offerings
Table 65. Jiangxi Shanxiang Targeted Small Molecule Drug Revenue (US$, Mn), (2017-2022)
Table 66. Yao Pharma Corporate Summary
Table 67. Yao Pharma Targeted Small Molecule Drug Product Offerings
Table 68. Yao Pharma Targeted Small Molecule Drug Revenue (US$, Mn), (2017-2022)
Table 69. CSPC Corporate Summary
Table 70. CSPC Targeted Small Molecule Drug Product Offerings
Table 71. CSPC Targeted Small Molecule Drug Revenue (US$, Mn), (2017-2022)
Table 72. CHIATAI Tianqing Corporate Summary
Table 73. CHIATAI Tianqing Targeted Small Molecule Drug Product Offerings
Table 74. CHIATAI Tianqing Targeted Small Molecule Drug Revenue (US$, Mn), (2017-2022)
Table 75. Simcere Corporate Summary
Table 76. Simcere Targeted Small Molecule Drug Product Offerings
Table 77. Simcere Targeted Small Molecule Drug Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Targeted Small Molecule Drug Segment by Type in 2021
Figure 2. Targeted Small Molecule Drug Segment by Application in 2021
Figure 3. Global Targeted Small Molecule Drug Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Targeted Small Molecule Drug Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Targeted Small Molecule Drug Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Targeted Small Molecule Drug Revenue in 2021
Figure 8. By Type - Global Targeted Small Molecule Drug Revenue Market Share, 2017-2028
Figure 9. By Application - Global Targeted Small Molecule Drug Revenue Market Share, 2017-2028
Figure 10. By Region - Global Targeted Small Molecule Drug Revenue Market Share, 2017-2028
Figure 11. By Country - North America Targeted Small Molecule Drug Revenue Market Share, 2017-2028
Figure 12. US Targeted Small Molecule Drug Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Targeted Small Molecule Drug Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Targeted Small Molecule Drug Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Targeted Small Molecule Drug Revenue Market Share, 2017-2028
Figure 16. Germany Targeted Small Molecule Drug Revenue, (US$, Mn), 2017-2028
Figure 17. France Targeted Small Molecule Drug Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Targeted Small Molecule Drug Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Targeted Small Molecule Drug Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Targeted Small Molecule Drug Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Targeted Small Molecule Drug Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Targeted Small Molecule Drug Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Targeted Small Molecule Drug Revenue Market Share, 2017-2028
Figure 24. China Targeted Small Molecule Drug Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Targeted Small Molecule Drug Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Targeted Small Molecule Drug Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Targeted Small Molecule Drug Revenue, (US$, Mn), 2017-2028
Figure 28. India Targeted Small Molecule Drug Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Targeted Small Molecule Drug Revenue Market Share, 2017-2028
Figure 30. Brazil Targeted Small Molecule Drug Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Targeted Small Molecule Drug Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Targeted Small Molecule Drug Revenue Market Share, 2017-2028
Figure 33. Turkey Targeted Small Molecule Drug Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Targeted Small Molecule Drug Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Targeted Small Molecule Drug Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Targeted Small Molecule Drug Revenue, (US$, Mn), 2017-2028
Figure 37. Bayer Targeted Small Molecule Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Eisai Targeted Small Molecule Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Zelgen Targeted Small Molecule Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Cipla Targeted Small Molecule Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Natco Pharma Targeted Small Molecule Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. AstraZeneca Targeted Small Molecule Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Novartis Targeted Small Molecule Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Roche Targeted Small Molecule Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bristol-Myers Squibb Targeted Small Molecule Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Pfizer Targeted Small Molecule Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. BEACON Pharma Targeted Small Molecule Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Jiangxi Shanxiang Targeted Small Molecule Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Yao Pharma Targeted Small Molecule Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. CSPC Targeted Small Molecule Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. CHIATAI Tianqing Targeted Small Molecule Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Simcere Targeted Small Molecule Drug Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Global Freckle-removing Medical and Beau..
The global market for Freckle-removing Medical and Beauty Eq..
+16467917070US (Toll Free)